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Gut inflammation contributes to the development of gut motility disorders in part
by disrupting the function and survival of enteric neurons through mechanisms that
involve oxidative stress. How enteric neurons regulate oxidative stress is still poorly
understood. Importantly, how neuron autonomous antioxidant mechanisms contribute
to the susceptibility of enteric neurons to oxidative stress in disease is not known. Here,
we discover that sirtuin-3 (Sirt3), a key regulator of oxidative stress and mitochondrial
metabolism, is expressed by neurons in the enteric nervous system (ENS) of the mouse
colon. Given the important role of Sirt3 in the regulation of neuronal oxidative stress in
the central nervous system (CNS), we hypothesized that Sirt3 plays an important role
in the cell autonomous regulation of oxidative stress by enteric neurons and that a loss
of Sirt3 increases neuronal vulnerability during intestinal inflammation. We tested our
hypothesis using a combination of traditional immunohistochemistry, oxidative stress
measurements and in vivo and ex vivo measures of GI motility in healthy and inflamed
wild-type (wt) and Sirt3 null (Sirt3−/−) mice. Our results show that Sirt3 is widely
expressed by neurons throughout the myenteric plexus of the mouse colon. However,
the deletion of Sirt3 had surprisingly little effect on gut function and susceptibility to
inflammation. Likewise, neither the genetic ablation of Sirt3 nor the inhibition of Sirt3
with antagonists had a significant effect on neuronal oxidative stress. Therefore, we
conclude that Sirt3 contributes very little to the overall regulation of neuronal oxidative
stress in the ENS. The functional relevance of Sirt3 in enteric neurons is still unclear but
our data show that it is an unlikely candidate to explain neuronal vulnerability to oxidative
stress during inflammation.
Keywords: Sirt3, sirtuin, autonomic, intestine, peripheral nervous system, oxidative stress
Abbreviations: Sirt, Sirtuin; GFAP, glial fibrillary acidic protein; IBD, Inflammatory Bowel Disease; DNBS, dinitrobenzene
sulfonic acid; ENS, enteric nervous system; ROS, reactive oxygen species; wt, wildtype.
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INTRODUCTION
The enteric nervous system (ENS) controls essential
gastrointestinal (GI) reflexes such as patterns of movement
(i.e., peristalsis), fluid exchange across the intestinal mucosa and
local blood flow (Furness, 2012). This becomes most evident
in disease when gut functions are impaired by changes to the
structure or neurochemistry of the ENS. Indeed, alterations to
the survival or function of enteric neurons are associated with
impaired gut function in a number of conditions such as old
age (Wade and Cowen, 2004; Camilleri et al., 2008), diabetes
(Chandrasekharan et al., 2011), inflammatory bowel diseases
(IBD; Gulbransen et al., 2012), achalasia (De Giorgio et al., 1999),
chronic intestinal pseudo-obstruction (Antonucci et al., 2008),
slow-transit constipation (De Giorgio et al., 2004), Parkinson’s
disease (PD; Wakabayashi et al., 1988; Beach et al., 2010; Devos
et al., 2013), irritable bowel syndrome (IBS; Lindberg et al., 2009;
Ohlsson et al., 2010) and infectious diseases (Coron et al., 2009;
Lourenssen et al., 2010).
Oxidative stress is one of the most important mechanisms
that contributes to ENS dysfunction in disease (Lih-Brody et al.,
1996; Thrasivoulou et al., 2006; Chandrasekharan et al., 2011;
Roberts et al., 2013; Brown et al., 2016). For example, the inability
to buffer reactive oxygen species is considered an important
factor in the susceptibility of inhibitory, nitrergic neurons to
injury in conditions such as diabetes (Chandrasekharan et al.,
2011) and inflammation (Sido et al., 1998; Esworthy et al., 2001;
Rezaie et al., 2007; Zhu and Li, 2012; Roberts et al., 2013)
and excitatory, cholinergic neurons in advanced age (Wade,
2002; Camilleri et al., 2008; Korsak et al., 2012; Saffrey, 2013).
Neurons continually generate reactive oxygen species during
normal functions because of their high energy demand to
sustain electrical signaling. Yet neurons express few anti-oxidant
defenses and have a low ability to cope with reactive oxygen
species. Therefore, even a subtle shift in the limited defense
mechanisms that neurons do possess could have major effects on
their susceptibility to disease. Despite the importance of oxidative
stress in neuronal susceptibility to cell injury in many enteric
neurodegenerative conditions, little is known about the factors
that regulate oxidative stress in enteric neurons.
Sirtuin-3 (Sirt3) is a member of the sirtuin family
of nicotinamide adenine nucleotide (NAD)–dependent
deacetylases that has emerged as an important regulator of
neuronal survival in times of stress (Schwer et al., 2002; Kim
et al., 2011; Weir et al., 2012; Chen et al., 2013; Dai et al., 2014).
In cultured neurons, the expression of Sirt3 is both necessary
(Kim et al., 2011) and sufficient (Kim et al., 2011; Shulyakova
et al., 2014) for neuroprotection in models of oxidant-induced
neurotoxicity and excitotoxicity. These neuroprotective actions
appear to stem mainly from Sirt3’s ability to activate key
scavengers of reactive oxygen species in mitochondria (Shi et al.,
2005; Sundaresan et al., 2009; Kim et al., 2010). Indeed, mice
deficient in Sirt3 exhibit higher levels of oxidative stress (Chen
et al., 2013) and display enhanced susceptibility to metabolic
diseases (Hirschey et al., 2011).
Given the important role of Sirt3 in the regulation of
neuronal oxidative stress in neurons from the central nervous
system (CNS), we hypothesized that Sirt3 is an important
regulator of oxidative stress in the ENS.We tested our hypothesis
using a combination of traditional immunohistochemistry,
oxidative stress measurements and in vivo and ex vivo measures
of GI motility in wild-type (wt) and Sirt3 null (Sirt3−/−) mice.
Our results show that Sirt3 is widely expressed by myenteric
neurons in the mouse colon. However, the deletion of Sirt3 has
surprisingly little effect on gut function and the susceptibility to
inflammation. Likewise, neither the genetic ablation of Sirt3 nor
its inhibition with antagonists has a significant effect on neuronal
oxidative stress. Our results provide the first evidence of Sirt3
expression in the ENS. However, the main function of Sirt3 in
enteric neurons is unclear because it does not appear to play a
major role in the regulation of oxidative stress by enteric neurons.
MATERIALS AND METHODS
Animals
Experimental protocols were reviewed and approved
by the Institutional Animal Care and Use Committee
at Michigan State University. Sirt3 null mice (129-
SIRT3tm1.1Fwa/J; RRID:IMSR_JAX:012755), hereafter referred
to as Sirt3−/−(Lombard et al., 2007), and background controls
(129S1/SvImJ; RRID:IMSR_JAX:002448), hereafter referred to
as wild-type (wt; The Jackson Laboratory, Bay Harbor, ME,
USA), of both sexes (8–10 weeks of age) were used for all
experiments unless otherwise stated. Male C57BL/6 mice (8–10
weeks of age) from Charles River Laboratories (Hollister, CA,
USA) were used in some experiments to test Sirt3 expression in
inflammation and to compare oxidative stress levels of myenteric
neurons. Mice were maintained in a temperature controlled 12
h light:12 h dark cycle environment with ad libitum access to
food and water. All genotyping was performed by the Research
Technology Support Facility at Michigan State University using
the standard PCR protocol supplied by Jackson Labs for Sirt3−/−
mice (information available at www.jax.org).
In Vivo Measures of Colonic Motility
Pellet Production
Mice were individually housed in clean, empty cages and fecal
output was monitored for 1 h beginning at Zeitgeber time +
3 for 5 consecutive days. Mice were acclimatized over the first
2 days and data was recorded over the last 3 days. Pellets
were collected as soon as they were produced and counted and
weighed to obtain a wet weight. Pellets were then dried overnight
to determine dry weight.
Colon Bead
Individually housed animals were fasted overnight and lightly
anesthetized with isoflurane. A 2mm bead was inserted 2 cm into
the colon and the time to expulsion recorded.
In Vivo Colitis
We used the dinitrobenzene sulfonic acid (DNBS) model to
induce colitis in mice (Gulbransen et al., 2012). Anesthetized
mice received an enema of DNBS (5.5 mg/mouse in 0.1 mL
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50% ethanol/50% saline) via a gavage needle inserted 3 cm into
the colon. Control animals received an enema of saline. We
monitored animal weight daily and 48 h after treatment, animals
were euthanized via cervical dislocation to collect tissue samples.
The extent of inflammation was scored using an established
macroscopic damage scoring system (Storr et al., 2009).
Contractility Studies
Longitudinally oriented segments of mouse intestine were
mounted between two platinum ring stimulating electrodes in
organ baths. Each intestinal segment was secured to a tissue
holder and connected to a force-displacement transducer (Grass
Instruments, Quincy, MA, USA). Frequency-response curves
(2–30 Hz) for neurogenic contractions and relaxations were
generated by electrical field stimulation (EFS) supplied through
the electrodes by a GRASS stimulator (S88, GRASS telefactor,
West Warwick, RI, USA) and data was charted with Labscribe
(iWorx, Dover, NH, USA). Tissue segments were placed under
0.5 g initial tension and allowed to equilibrate for 20 min.
Neurogenic relaxations were studied in tissues precontracted
with 5 µM prostaglandin F2-α (PGF2α). Bethanechol (BCH,
10 µM) was used to assess the maximum contractile response
and tetrodotoxin (TTX, 0.3µM)was applied to block neurogenic
responses.
Whole-Mount Immunohistochemistry
Whole-mount preparations of colonic myenteric plexus and
longitudinal muscle (LMMP) were prepared from tissue fixed in
Zamboni’s fixative (Nasser et al., 2007) or 4% paraformaldehyde
(PFA; Joseph et al., 2011). Nonspecific labeling was blocked by
incubating tissue for 45 min in a solution containing 4% normal
donkey serum or goat serum, 0.4% Triton X-100, and 1% bovine
serum albumin. Primary antibodies were applied overnight at
room temperature and secondary antibodies were applied for 2
h at room temperature. Antibody details are supplied in Table 1.
Images were acquired through the 40X objective (Planfluor, 0.75
numerical aperture) of an upright epifluorescence microscope
(Nikon Eclipse Ni, Melville, NY, USA) with a Retiga 2000R
camera (QImaging, Surrey, BC, Canada) controlled by QCapture
Pro 7.0 software (QImaging) or by confocal imaging using the
Plan-Aprochromat 60X oil immersion objective (1.42 numerical
aperture) of an inverted Olympus Fluoview FV1000 microscope
(Olympus, Center Valley, PA, USA). Software settings were
established using the immunoreactivity of each antibody in
control tissues and then kept constant for all remaining tissues.
Thiol Oxidation
We quantified neuronal thiol oxidation as a measure of oxidative
stress as previously described (Mullett et al., 2013). Briefly,
reduced (-SH) and oxidized (-SS) thiols were labeled with 1 µM
Alexa Fluor 680 C2 maleimide and 1 µM Alexa Fluor 546 C5
maleimide, respectively. Dyes were dissolved in 4% PFA, 0.02%
Triton X-100 and 1 mM N-ethylymaleimide in PBS. Tissue was
washed in 5mM tris(2-carboxyethyl)phosphine hydrochloride to
convert oxidized thiols to reduced thiols. Images were obtained
by epifluorescence microscopy as described above and the
TABLE 1 | Antibodies used in this study.
Antibody Source Dilution
Primary antibodies
Goat anti-Calretinin Swant, Switzerland; CG1 1:1000
Guinea Pig anti-CGRP Peninsula Labs, San Carlos, CA, USA; T-5053 1:500
Chicken anti-GFAP Abcam, Cambridge, MA, USA; ab4674 1:1000
HuC/D Biotinylated Invitrogen, Carlsbad, CA, USA; A-21272 1:200
Sheep anti-nNos Millipore, Darmstadt, Germany; ab1529 1:500
Rabbit anti-Sirt3 Millipore, Darmstadt, Germany; 07-1596 1:100
Rabbit anti-Sirt3 Cell Signaling, Danvers, MA, USA; 5490 1:200
Rabbit anti-Sirt3 Abcam, Cambridge, MA, USA; Ab86671 1:200
Secondary antibodies
Donkey anti-Rabbit 488 Jackson, Bay Harbor, ME, USA; 711-545-152 1:400
Goat anti-Rabbit 488 Lifetech, Carlsbad, CA, USA; A-11034 1:400
Streptavidin 488 Jackson, Bay Harbor, ME, USA; 016-540-084 1:400
Donkey anti-Goat 568 Invitrogen, Carlsbad, CA, USA; A-11057 1:400
Donkey anti-Sheep 568 Invitrogen, Carlsbad, CA, USA; A-21099 1:400
Goat anti-Chicken 568 Invitrogen, Carlsbad, CA, USA; A-11041 1:400
Donkey anti-Guinea
Pig 594
Jackson, Bay Harbor, ME, USA; 706-585-148 1:400
Streptavidin 594 Jackson, Bay Harbor, ME, USA; 016-580-084 1:400
ratio of 546-maleimide/680-maleimide (SS/SH) calculated with
ImageJ software (NIH).
Drugs/Chemicals
Tenovin-6 was purchased from Cayman Chemicals (Ann Arbor,
MI, USA). All other reagents were purchased from Sigma-
Aldrich (St. Louis, MO, USA).
Data Analysis
Cell counts were performed using the cell counter plug-
in of ImageJ software. Individual neuron subpopulations are
presented as a percentage of total enteric neuron numbers
defined by HuC/D-immunoreactivity. Enteric neuron numbers
are presented as the ganglionic neuronal packing density. We
calculated the neuron packing density per ganglion by using
GFAP-immunoreactivity to demarcate the borders of each
ganglion and HuC/D-immunoreactivity to count the number
of neurons within that two-dimensional area. Ganglionic GFAP
fluorescence density was quantified in ganglia from confocal
z-stack images. Each image was imported into ImageJ and
mean gray values of GFAP fluorescence and ganglionic area
were recorded for each ganglion. GFAP fluorescence density
(integrated density) was calculated as the product of area and
mean gray value (McCloy et al., 2014) and is reported as the
intensity in arbitrary fluorescence units (AFU) per µm2 of
ganglionic area. Counts were performed on a minimum of 10
ganglia per animal and averaged to obtain an average packing
density for that animal.N values represent the number of animals
in each experiment.
Statistical Analysis
Prism 6 software (Graphpad, La Jolla, CA, USA) was used
for all statistical analyses and the generation of graphs. Data
was analyzed using either a two-way ANOVA (with Bonferroni
post hoc test) or a Student’s t-test, where appropriate. A P value
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 March 2016 | Volume 10 | Article 73
Bubenheimer et al. Role of Sirtuin-3 in the Enteric Nervous System
less than 0.05 was considered statistically significant. All data are
presented as mean± standard error of the mean (SEM).
RESULTS
Expression of Sirtuin-3 in the Mouse
Intestine
Sirtuin-3 (Sirt3) is highly expressed inmetabolically active tissues
that are rich in mitochondria such as the brain and the heart
(Lombard et al., 2007). Sirt3 is also expressed in the stomach (Shi
et al., 2005), but whether Sirt3 expression extends to the distal
regions of the gastrointestinal tract is not known. Therefore,
we began by exploring the expression of Sirt3 in samples of
mouse colon using PCR to assess the presence of Sirt3 mRNA
and western blots to determine the presence of Sirt3 protein
(Figure 1). Our results show robust expression of both Sirt3
message (Figure 1A) and protein (Figure 1B) in the colons of
wt mice. Human Sirt3 is expressed in two forms: a long form of
∼44 kDa that localizes to the nucleus and a short form of ∼28
kDa that is localized to mitochondria (Schwer et al., 2002). Most
available evidence shows that mice only express one form of Sirt3
that is equivalent to the human truncated form (∼28 kDa; Scher
et al., 2007). However, some evidence suggests that mice express
both long and short forms of Sirt3 (Sundaresan et al., 2009). Our
results show clear bands at both 44 and 28 kDa in samples from
wt mouse colon (Figure 1B). However, only the band at 28 kDa
was absent in samples from Sirt3−/− mice. These results agree
with the conclusion that only one form of Sirt3 is present in the
mouse intestine and that this form corresponds to the truncated
(28 kDa) product in humans.
Localization of Sirtuin-3 within the Enteric
Nervous System
Given that Sirt3 is highly expressed in the brain (Lombard
et al., 2007) and our results show that Sirt3 is expressed in the
colon (Figure 1), we reasoned that enteric neurons would be
one site of high Sirt3 expression within the colon. To explore
this possibility, we performed dual-label immunohistochemistry
experiments with antibodies against HuC/D (to identify enteric
neurons) and Sirt3 (to localize Sirt3 protein). In all, we evaluated
the labeling of three commercial antibodies against Sirt3 in
the ENS (see Table 1 for antibody details). The pattern of
labeling produced by each of the three antibodies against
Sirt3 that we tested was consistent with neuronal labeling
in the ENS (for example, see Figure 2). However, given the
questionable specificity of some antibodies (Baker, 2015), we
performed careful control experiments with control peptides
and tissue from Sirt3 null animals to validate the labeling
of each antibody. Labeling was completely abolished in all
cases by preadsorption with the corresponding peptide (data
not shown); suggesting that each of the three antibodies is
specific against the peptide that it was raised against. Despite
all being specific for the corresponding peptides, only one
antibody from Cell Signaling (Danvers, MA, USA) was specific
for Sirt3 protein when we evaluated labeling in tissue from
Sirt3−/− mice using immunohistochemistry and western blot
analyses (western blot data shown in Figure 1B). The other
two antibodies still exhibited strong labeling in knockout
tissue. Based on these results, we concluded that the other
two antibodies were not specific for Sirt3 protein and/or not
suitable for our application and we chose to perform the
remainder of our experiments with the antibody from Cell
Signaling.
Our results show widespread Sirt3 immunoreactivity in
myenteric neurons in the mouse colon (Figure 2). In our study,
we were unable to find any HuC/D-immunoreactive neurons
that did not also display some level of Sirt3 immunoreactivity
(Figures 2A–A”). The most intense Sirt3 immunoreactivity
that we observed was present in neuronal varicosities and
co-localized well with labeling for calcitonin gene-related
peptide (CGRP; Figures 2B–B”). Sirt3 immunoreactivity was
FIGURE 1 | Representative images showing detection of Sirt3 in the mouse colon by RT-PCR (A) and western blot (B). Tissue from Sirt3−/− mice was
used as a negative control. PCR amplification of Sirt3 mRNA (A) shows the expected products at 562 bp for wt Sirt3 and 200 bp for mutant Sirt3 (Sirt3−/−). Western
blots for Sirt3 protein (B) show two bands potentially corresponding to the full-length nuclear protein at 44 kDa and the processed mitochondrial form at 28 kDa.
However, only the band at 28 kDa is absent in Sirt3−/− mice and this band corresponds to the single known form of mouse Sirt3.
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FIGURE 2 | Myenteric neurons in the mouse colon express Sirt3. Panels show confocal fluorescence microscopy images of dual-label immunohistochemistry
for Sirt3 (green, A–D) and either the neuronal marker HuC/D (magenta, A’), calcitonin gene-related peptide (CGRP; magenta, B’), nNOS (magenta, C’) or calretinin
(magenta, D’). Overlays of each combination are shown in (A”–D”). The areas demarcated by the dashed boxes in the overlay images are shown as enlarged images
in the panels at far right. Arrows in these images highlight several regions of co-localization. The scale bar in D” = 20 µm and applies to (A–D”). All scale bars in the
enlarged images at right = 5 µm. Labeling is representative of experiments performed on tissue from a minimum of three mice.
present in neurons immunoreactive for nNOS and neurons
immunoreactive for calretinin (Figures 2C,D). These results
suggest that Sirt3 is broadly expressed by myenteric neurons
and not confined to a particular neuronal subtype. However,
Sirt3 may be expressed at different levels in subpopulations
of enteric neurons because Sirt3 immunoreactivity appeared
to label nitrergic neurons more intensely than calretinin-
immunoreactive neurons (compare Figures 2C”,D”) and
nitrergic nerve fibers at the level of the smooth muscle displayed
strong immunoreactivity for Sirt3 (see magnification image of
Figure 2C”).
Effect of the Ablation of Sirtuin-3 on Gut
Function
The results of our expression analysis above show that Sirt3
is highly expressed by myenteric neurons in the mouse colon.
Based on these data, we hypothesized that a loss of Sirt3
would disrupt the normal neural control of gut function
and/or the susceptibility of enteric neurons to pathological
conditions that involve oxidative stress, such as inflammation.
We began to test our hypothesis by assessing how the loss
of Sirt3 in Sirt3−/− mice impacts the neuronal control of
gut function. We assessed gut function in two ways: first,
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by performing isometric muscle tension recordings in isolated
segments of intestine and second, by measuring colonic output
in vivo.
We began our muscle tension recordings by assessing the
contractile ability of each segment of colon with the muscarinic
agonist, bethanechol (BCH, 10 µM). BCH elicited similar
contractile responses in tissue segments from both wt and
Sirt3−/− mice (Figure 3A). On average, these responses were
0.214 ± 0.026 g in wt and 0.218 ± 0.017 g in Sirt3−/− tissues
(P > 0.05). These data show that the contractile capacity of
the intestinal smooth muscle is not affected by the ablation of
Sirt3. Next, we tested whether the ability of enteric neurons to
drive contractions is affected by the ablation of Sirt3 by assessing
neurogenic contractions driven by EFS. EFS elicited contractile
responses of equal magnitude in tissue segments from both
wt and Sirt3−/− mice (Figure 3A). On average, EFS-evoked
responses were 0.296 ± 0.048 g in wt and 0.294 ± 0.032 g in
Sirt3−/− tissues (P > 0.05). Overall, we found no evidence of
altered neurogenic contractions between wt and Sirt3−/− tissue
(Figure 3A). Next, we assessed neurogenic relaxations provoked
by EFS in tissue samples pre-contracted with prostaglandin
F2α (PGF2α, 5 µM; Figure 3B). These experiments revealed a
significant defect in neurogenic relaxations driven by frequencies
between 3–25 Hz in tissues from Sirt3−/− mice (Data shown:
EFS at 20 Hz elicited relaxation responses that averaged 0.132
± 0.015 g in wt and 0.074 ± 0.013 g in Sirt3−/− tissues;
n = 5, P = 0.0192; Figure 3B). These results suggest that Sirt3
is important in the normal functions of inhibitory neurons in
the ENS but is dispensable in the normal functions of excitatory
neurons.
FIGURE 3 | Effect of the ablation of Sirt3 on gut function in healthy animals. (A) Contractile responses of longitudinal segments of colon driven by
bethanechol (BCH, 10 µM) or electrical field stimulation (EFS) are similar in mice with wild type Sirt3 (wt) and Sirt3 null mice (Sirt3−/−; n = 5 animals per group,
P > 0.05, Student’s t-test). (B) Relaxations driven by EFS (at 20 Hz) in pre-contracted (PGF2α, 5 µM) longitudinally-oriented segments of colon from Sirt3−/− mice
and their respective wt controls. EFS produced significantly smaller relaxations in tissues from Sirt3−/− mice than wt controls (n = 5 animals per group, ∗P = 0.0192,
Student’s t-test). Distal colonic transport time (C), the number of fecal pellets produced per hour (D) and pellet composition (E,F) are comparable between male
and female agouti wt and Sirt3−/− mice (n = 4 animals per group; P > 0.05, 2-way ANOVA).
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 March 2016 | Volume 10 | Article 73
Bubenheimer et al. Role of Sirtuin-3 in the Enteric Nervous System
Next, we tested the hypothesis that the deficit in the inhibitory
component of neuromuscular control that we observed in vitro
would translate to poor colonic motility in vivo. We tested
our hypothesis by assessing distal colonic transit time and by
measuring the fecal pellet output rate and content in Sirt3−/−
and wt mice (Figures 3C,D). Our results show that colonic
transit time is not significantly affected by the deletion of Sirt3
in either male or female mice (Figure 3C). Likewise, Sirt3−/−
mice produce an equal number of pellets per hour as wt mice
(wt female 9 ± 0.9 pellets, Sirt3−/− female 9 ± 0.6 pellets, wt
male 8 ± 1.2 pellets, Sirt3−/− male 8 ± 0.5 pellets; P = 0.833;
2-way ANOVA; Figure 3D). The pellets produced contained
a similar content of fecal matter and liquid (total dry weight
of fecal matter: wt female 72.4 ± 12 mg, Sirt3−/− female
87.9 ± 11 mg, wt male 95.1 ± 1.6 mg, Sirt3−/− male 83.8
± 7.5 mg; P = 0.390; 2-way ANOVA; total wet weight of
fecal matter: wt female 132 ± 34 mg, Sirt3−/− female 160 ±
14 mg, wt male 203 ± 12 mg, Sirt3−/− male 177 ± 20 mg;
P = 0.940; 2-way ANOVA; Figures 3E,F). These results show
that the defect in neurogenic relaxations that we observed
in vitro is not a significant barrier to normal colonic transit
in vivo.
Effects of the Ablation of Sirtuin-3 on
Enteric Neurodegeneration During Gut
Inflammation
Colonic inflammation increases oxidative stress in myenteric
neurons and myenteric oxidative stress contributes to
neurodegeneration during inflammation (Brown et al., 2016).
Sirt3 plays a prominent role in the protection of central neurons
from oxidative stress and decreasing Sirt3 expression increases
their susceptibility to apoptosis (Kim et al., 2011; Dai et al.,
2014). Therefore, we expected that mice deficient in Sirt3
would be more susceptible to myenteric neurodegeneration
during inflammation. We tested our hypothesis using the
DNBS model of colitis because we, and others, have shown
that this model drives myenteric neurodegeneration through
mechanisms that involve neuronal oxidative stress (Gulbransen
et al., 2012; Roberts et al., 2013; Brown et al., 2016). DNBS
drove colitis to an equal extent in both wt and Sirt3−/− mice
(Figure 4). Loss of Sirt3 did not affect the extent of macroscopic
tissue damage (Figure 4A) nor did it significantly change the
pattern of weight loss experienced by the mice during the
acute episode of colitis (Figure 4B). We did observe greater
weight gain in non-inflamed Sirt3−/− mice than healthy wt
mice over the course of the experiment (Figure 4B) and
this observation is in line with published data showing that
Sirt3−/− mice gain weight more rapidly than wt mice (Hirschey
et al., 2011). We also observed enlarged stomachs in all mice
exposed to DNBS regardless of their sex or genotype (data
not shown). This observation was surprising because we have
never observed this phenomenon in DNBS-colitis experiments
with C57BL/6 mice (see Gulbransen et al., 2012; Brown et al.,
2016). However, we did not pursue this finding further because
it was independent of Sirt3 and beyond the scope of the
current study.
FIGURE 4 | Assessment of gross inflammation driven by
dinitrobenzene sulfonic acid (DNBS)-colitis in wt or Sirt3−/− mice as
measured by macroscopic damage scoring (A) and monitoring
changes in body weight (B; n = 5–7 per group, ∗P < 0.05, ∗∗∗P < 0.005,
∗∗∗∗P < 0.001, 2-way ANOVA).
The results above suggest that Sirt3 is not an essential
protective factor against the gross inflammatory insult driven
by DNBS colitis in mice. To gain more specific insight into the
role of Sirt3 in the protection of neurons, we performed whole-
mount immunohistochemistry to determine if neuronal Sirt3
expression changes during inflammation and if a loss of Sirt3
alters the susceptibility to neurodegeneration and neurochemical
remodeling in themyenteric plexus during inflammation.We did
not detect any obvious changes in Sirt3 expression or localization
within the myenteric plexus during DNBS colitis in wt mice
(Figure 5). This outcome suggests that inflammation does not
cause overt changes in Sirt3 that could account for neuronal
susceptibility in the intestine. Rather, the maintenance of Sirt3
expression could be important to protect the remaining neurons.
To test if the maintenance of Sirt3 expression is necessary to
protect enteric neurons, we conducted inflammation studies in
Sirt3−/− mice. The packing density of HuC/D-immunoreactive
myenteric neurons was not significantly different between
healthy Sirt3−/− and wt animals (2043 ± 85 neurons/mm2
in wt vs. 1709 ± 153 neurons/mm2 in Sirt3−/−, Figure 6).
Likewise, the neurochemical composition of myenteric neurons
was not significantly affected by the deletion of Sirt3 because we
observed equal percentages of nNOS-immunoreactive neurons
(Figure 7) and calretinin-immunoreactive neurons (Figure 8) in
healthy Sirt3−/− and wt animals. DNBS-colitis drove myenteric
neurodegeneration to a similar extent in Sirt3−/− animals as
wt mice (31% neuron loss in wt vs. 25% neuron loss in
Sirt3−/−, Figure 6). This was an indiscriminate loss of myenteric
neurons in bothwt and Sirt3−/−mice because the neurochemical
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FIGURE 5 | Sirt3 expression in healthy and inflamed C57BL/6 mice. Panels show confocal fluorescence microscopy images of dual-label
immunohistochemistry for Sirt3 (green, A,B) and the neuronal marker HuC/D (magenta, A’,B’). Overlays of each combination are shown in (A”,B”). The scale bar in
panel B” = 50 µm and applies to (A–B”). Labeling is representative of experiments performed on tissue from a minimum of four mice.
makeup of the remaining HuC/D-immunoreactive neurons was
not significantly different from healthy mice (Figures 7, 8).
Interestingly, glia failed to up-regulate glial fibrillary acidic
protein (GFAP) expression during inflammation in Sirt3−/−
mice (Figure 6F). Together, these results show that the loss
of Sirt3 does not increase the susceptibility of myenteric
neurons to neurodegeneration during inflammation. However,
the lack of glial GFAP up-regulation suggests that Sirt3−/−
mice may experience less neuroinflammation in the myenteric
plexus. Alternatively, our results indicate that Sirt3 molecular
signaling might be necessary for reactive gliosis. This hypothesis
should be tested in the future with cell-specific knockouts of
Sirt3.
Effects of Sirtuin-3 Inhibition on the Redox
State of Enteric Neurons
The fact that the deletion of Sirt3 did not affect the susceptibility
of enteric neurons to inflammation was very surprising because
reducing Sirt3 dramatically increases neuronal vulnerability in
neurons isolated from the brain (Kim et al., 2011; Dai et al., 2014;
Shulyakova et al., 2014). This difference suggests that there may
be important differences in the function of Sirt3 between enteric
and central neurons or important differences between the roles
of Sirt3 in neurons in vivo vs. in vitro. One interpretation of the
above data is that Sirt3 plays a much less prominent role in the
regulation of oxidative stress in enteric neurons. We tested this
hypothesis by measuring how the deletion of Sirt3 affects the
redox state of enteric neurons in healthy and inflamed animals.
Our results show that the ablation of Sirt3 in Sirt3−/− mice
does not affect the oxidative balance of myenteric neurons in
healthy animals (Figure 9A). In agreement with our previous
work (Brown et al., 2016), myenteric neurons in tissue from wt
mice with active DNBS-colitis exhibit higher levels of oxidative
stress. However, the ablation of Sirt3 did not exacerbate oxidative
stress in enteric neurons during inflammation (Figure 9A).
To the contrary, myenteric neurons from inflamed Sirt3−/−
mice exhibited less oxidative stress than neurons in tissue from
healthy wt mice, healthy Sirt3−/− mice or inflamed wt mice
(Figure 9A).
The above findings were entirely unexpected and puzzling.
One possible explanation for these results could be that
compensatory mechanisms are enacted in the constitutive
knockout animal that efficiently buffer reactive oxygen species
in the absence of Sirt3. Therefore, we used a pharmacological
approach to assess the effects of acutely blocking Sirt3 function
with the drug Tenovin-6 (Tnv6, 100 µm). In agreement with
our in vivo work with Sirt3−/− mice, we found that blocking
Sirt3 function acutely had no effect on the oxidative balance
of myenteric neurons in tissue (Figures 9B,C). Interestingly,
myenteric neurons in tissue from the wt agouti background
mouse strain were less sensitive to oxidative stress induced by
H2O2 (0.1 M) thanmyenteric neurons in tissue fromwt C57BL/6
mice (Figures 9B,C). This may suggest that the handling of
oxidative stress by myenteric neurons is fundamentally different
in these two common mouse strains. Despite this difference, the
inhibition of Sirt3 had absolutely no effect on baseline neuronal
redox state or their susceptibility to an oxidative insult (driven
by H2O2) in either strain. In all, these results show that Sirt3
does not play a major role in the antioxidant defenses of enteric
neurons.
DISCUSSION
The cell autonomous mechanisms that enteric neurons utilize
to regulate oxidative stress are still poorly understood. Here,
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FIGURE 6 | Enteric neuron survival and glial reactivity in healthy and inflamed wt and Sirt3−/− mice. (A–D”) show dual-label fluorescence
immunohistochemistry for HuC/D (cyan, A–D) and GFAP (grayscale, A’–D’) in myenteric ganglia from saline- (A–A”, C–C”) or DNBS-treated (B–B”, D–D”) wt (A–B”)
or Sirt3−/− (C–D”) mice. Overlays are shown in (A”–D”). Scale bar in D” = 50 µm and applies to all images. (E) Quantification of myenteric neuron packing density.
(F) Quantification of ganglionic GFAP fluorescence density (afu/µm2). n = 3–5 animals per group, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, 2-way ANOVA.
we show that enteric neurons express Sirt3; a key regulator of
oxidative stress in CNS neurons. Sirt3 is widely expressed by
neurons throughout the myenteric plexus of the mouse colon
and its expression is potentially enriched in nitrergic neurons.
Our in vivo experiments show that Sirt3 does play a role in the
normal functions of nitrergic neurons because we observed a
deficit in neurogenic relaxations in tissue from Sirt3−/− mice.
However, Sirt3 seems to play a minor role, if any, in the
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FIGURE 7 | The percentage of myenteric neurons that express calretinin is not altered by DNBS-colitis in wt or Sirt3−/− mice. (A–D”) show dual-label
fluorescence immunohistochemistry for HuC/D (cyan, A–D) and calretinin (grayscale, A’–D’) in myenteric ganglia from saline- (A–A”, C–C”) or DNBS-treated
(B–B”, D–D”) mice. Overlays are shown in (A”–D”). Scale bar in D” = 50 µm and applies to all images. (E) The percentage of HuC/D immunoreactive neurons that
also display immunoreactivity for calretinin in healthy and inflamed mice with wt or Sirt3−/− genotypes (n = 4–5 animals per group, P > 0.05, 2-way ANOVA).
regulation of oxidative stress by enteric neurons. Mice deficient
in Sirt3 have an incredibly unremarkable GI phenotype and do
not exhibit gross abnormalities in GI function or ENS structure.
Likewise, the ablation of Sirt3 does not affect the susceptibility
of enteric neurons to degeneration during colitis or their redox
state.
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FIGURE 8 | The percentage of myenteric neurons that express nNOS is not altered by DNBS-colitis in wt or Sirt3−/− mice. (A–D”) show dual-label
fluorescence immunohistochemistry for HuC/D (cyan, A–D) and nNOS (grayscale, A’–D’) in myenteric ganglia from saline- (A–A”,C–C”) or DNBS-treated
(B–B”,D–D”) mice. Overlays are shown in (A”–D”). Scale bar in D” = 50 µm and applies to all images. (E) Quantification of the percentage of HuC/D
immunoreactive neurons that also display immunoreactivity for nNOS in healthy and inflamed mice with wt or Sirt3−/− genotypes (n = 4–5 animals per group,
P > 0.05, 2-way ANOVA).
The minor functional role of Sirt3 in the regulation of
oxidative stress by enteric neurons is surprising given the major
role that Sirt3 plays in the handling of oxidative stress by
other populations of neurons in the CNS (Kim et al., 2011;
Weir et al., 2012; Dai et al., 2014; Shulyakova et al., 2014).
For example, Sirt3 expression is rapidly up-regulated by cortical
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FIGURE 9 | Neither the ablation of Sirt3 nor the inhibition of Sirt3 has a
significant effect on myenteric neuron redox balance. (A) Thiol oxidation
measurements (ratio of oxidized/reduced glutathione) in myenteric neurons
from saline or DNBS-treated wild type (wt) and Sirt3−/− animals (n = 3–5
animals, ∗∗P < 0.01 vs. wt DNBS-treated, ANOVA). (B,C) Neuronal thiol
oxidation measurements in whole-mount preparations from (B) wt agouti mice
and (C) wt C57BL/6 mice treated with the oxidative stressor hydrogen
peroxide (H2O2) and/or the Sirt3 inhibitor Tenovin-6 (Tnv-6, 100µm; n = 3
animals, ∗∗P < 0.01, ANOVA).
neurons during excitotoxic insults and the increase in Sirt3 is
an important defensive mechanism against oxidative stress that
aids neuron survival (Kim et al., 2011). Sirt3 is also thought
to play an important role in the regulation of oxidative stress
by non-neuronal cells such as microglia (Rangarajan et al.,
2015), skeletal myocytes (Jing et al., 2011), cardiomyocytes
(Chen et al., 2013) and brown adipocytes (Shi et al., 2005).
We did not observe any evidence of a similar role of Sirt3
in enteric neurons in our study. Enteric neurons did not
exhibit higher levels of oxidative stress in Sirt3−/− mice and
the acute inhibition of Sirt3 with the antagonist, tenovin-6,
also had no effect on neuronal oxidative stress. These results
suggest that Sirt3 fulfills a much different function in enteric
neurons than in other cells and possibly that enteric neurons
are fundamentally unique in the way that they handle oxidative
stress. Importantly, the lack of functional Sirt3 neuroprotective
mechanisms may partially explain why enteric neurons are
highly susceptible to oxidative injury and death in many
enteric neurodegenerative conditions (Wade and Cowen, 2004;
Thrasivoulou et al., 2006; Korsak et al., 2012; Roberts et al., 2013;
Brown et al., 2016).
An alternate explanation for our results is that Sirt3 is
more important for the regulation of neuronal oxidative stress
in culture conditions than it is in vivo. Indeed, the notion
that Sirt3 plays a major role in the handling of neuronal
oxidative stress has largely been based on data collected from
cell culture model systems (Kim et al., 2011; Dai et al., 2014;
Shulyakova et al., 2014). We assessed neuronal oxidative stress
in tissue samples shortly after collecting them from the animal.
Thus, our data exclude the possible confounding effects of the
culture environment. If Sirt3 does in fact play a major role
in the regulation of neuronal oxidative stress, mice lacking
Sirt3 should be incredibly susceptible to neurodegeneration
and would be expected to exhibit phenotypic abnormalities
that reflect deficits in nervous system function. This is not
the case. To the contrary, Sirt3 null mice have a surprisingly
unremarkable phenotype despite having mitochondrial protein
hyperacetylation at the biochemical level (Lombard et al., 2007).
These discrepancies raise some interesting questions about
what the primary role of Sirt3 is in the nervous system.
Sirt3 undoubtedly plays an important role in the regulation
of oxidative stress under some conditions but whether these
conditions reflect the circumstances under which Sirt3 would
normally function remains unclear.
If Sirt3 does contribute to the regulation of oxidative stress
by enteric neurons, our data would suggest that this is a very
minor contribution. Indeed, non-cell autonomous mechanisms
mediated by enteric glia may play a more major role in the
regulation of the overall redox state of enteric neurons than cell
autonomous mechanism under normal conditions (Abdo et al.,
2010, 2012). This major influence of glia likely masks any minor
effects of the ablation of Sirt3 on the oxidative balance of enteric
neurons in vivo. It is interesting to speculate that the same would
be true of central neurons if they were assessed in their native
environment where astrocytes regulate their oxidative stress vs.
in culture when neuron autonomous mechanisms would be
isolated and appear more prominent.
In conclusion, our study provides the first evidence of Sirt3
expression by enteric neurons. Sirt3 has received a great deal
of attention as a key regulator of metabolism (Nogueiras et al.,
2012) and neuroprotection against oxidative stress (Yin et al.,
2015). Indeed, decreased Sirt3 expression is now being proposed
by some as a potential biomarker for disease (Yu and Sun, 2015).
However, we find very little evidence that would support the
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conclusion that low Sirt3 expression increases the susceptibility
of the ENS, or the colon in general, to disease. Rather, our
results are more in line with the conclusion that neuronal
Sirt3 contributes very little to the overall regulation of neuronal
oxidative stress and that non-cell autonomous mechanism are
more important. Understanding the precise function of Sirt3 in
enteric neurons will be an important issue for future molecular
studies to dissect because we show that it plays a role in the
normal functions of inhibitory neurons. Given the important
role of Sirt3 in mitochondrial protein acetylation, a more
thorough understanding of the targets and activity of Sirt3 in
enteric neurons might be important to understand neuronal
vulnerability or function in the gut.
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